Navigation Links
Statins May Be Harmful After Stroke
Date:1/10/2011

By Steven Reinberg
HealthDay Reporter

MONDAY, Jan. 10 (HealthDay News) -- Patients given cholesterol-lowering drugs called statins after suffering a stroke caused by bleeding in the brain may be at an increased risk of having another such stroke, a new study suggests.

It is well-known that statins help reduce the risk of heart disease and ischemic stroke, where a clot blocks a blood vessel in the brain. However, whether statins also benefit patients who have had a hemorrhagic (bleeding) stroke is unclear.

Lead researcher Dr. Steven M. Greenberg, director of the Hemorrhagic Stroke Research Program at Massachusetts General Hospital in Boston, said that "there is a group of patients who have to think carefully about whether they are getting benefit from being on a statin. Those are people who have had a hemorrhagic stroke and survived it and are trying to figure out how to prevent future disease."

"For some of those people, the risk of being on the medication may be greater than the risk of not being on it," Greenberg said.

However, a lot depends on the location of the stroke in the brain, added lead study author Dr. M. Brandon Westover, a neurology resident at Massachusetts General.

"In one case [bleeding in the cerebrum] our answer was pretty clear-cut -- you shouldn't be on those medicines," he said.

"But for hemorrhages deep in the brain, usually caused by long-term high blood pressure, the risk of a new hemorrhage is lower, so our results were less clear-cut," he said. "But you are probably a little better off not being on the medication in that case, too."

The report is published in the Jan. 10 online edition of the Archives of Neurology.

For the study, Westover and his colleagues used a computer program called a Markov decision model to figure out whether statins were a benefit or risk to patients after a hemorrhagic stroke.

Using this model, they were able to simulate patient's conditions to show combinations of events that could lead to the increased risk of stroke or heart disease, change in quality of life, or death.

The results of their study indicated that patients taking statins had a 14 percent to 22 percent greater risk of having another hemorrhagic stroke, particularly patients whose stroke was a lobar intracerebral hemorrhage, or bleeding in the part of the brain called the cerebrum.

For these patients, the risk of taking a statin outweighed any benefit from the drug, the researchers found.

"However, the last word isn't in on how consistently statins increase the risk for a second hemorrhagic stroke," Greenberg said. "But there is at least enough now to make it something to be discussed between patient and doctor."

For patients whose bleeding occurred deep within the brain, the benefit versus the risk of statins was more balanced, they noted. This suggests that whether or not to prescribe a statin after hemorrhagic stroke may depend on the location of the stroke in the brain.

Why statins might increase the risk of hemorrhagic stroke is unknown, Westover said. It may be due to an increased risk of brain bleeding among people with low cholesterol, or perhaps statins prevent clotting, he said.

Greenberg noted that the use of statins to prevent a second ischemic stroke, one caused by a clot in a blood vessel in the brain, is standard care and has been shown to be effective.

Dr. Larry B. Goldstein, director of the Duke Stroke Center and author of an accompanying journal editorial, said the current data on the use of statins after a hemorrhagic stroke is limited but he generally supports this latest finding.

Dr. Ralph L. Sacco, president of the American Heart Association and chairman of neurology at the University of Miami Miller School of Medicine, said that the recent guidelines from the American Heart Association recommend statins after ischemic stroke.

"We believe that people with a lobar hemorrhage are at greater risk of bleeding from a variety of drugs, possibility including statins," he said. "It is not routine that we would start a statin after intracerebral hemorrhage."

More information

For more information on hemorrhagic stroke, visit the American Stroke Association.

SOURCES: Steven M. Greenberg, M.D., Ph.D., director, Hemorrhagic Stroke Research Program, M. Brandon Westover, M.D., Ph.D., neurology resident, both Massachusetts General Hospital, Boston; Larry B. Goldstein, M.D., director, Duke Stroke Center, Duke University, Durham, N.C.; Ralph L. Sacco, M.D., president, American Heart Association, and chairman, neurology, University of Miami Miller School of Medicine, Miami; Jan. 10, 2011, Archives of Neurology, online


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Statins OK for Patients With Abnormal Liver Function: Study
2. Statins Dont Reduce Colon Cancer Risk, Study Finds
3. Statins did not reduce colorectal cancer in WHI analysis
4. Statins dont prove useful for general pediatric lupus population
5. Aspirin, Statins May Reduce Problems After Heart Surgery
6. Statins May Guard Against Rheumatoid Arthritis
7. Study Suggests Statins Could Help Some With Normal Cholesterol
8. Statins, Painkillers May Upset PSA Test Results
9. Some on Statins May Not Need Boost in Good Cholesterol
10. Statins May Not Be as Helpful for Those Without Heart Disease
11. Statins May Lower Rates of Prostate Cancer Recurrence
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Statins May Be Harmful After Stroke
(Date:6/27/2017)... and London UK (PRWEB) , ... June 27, 2017 , ... ... to a clinical study is whether they can trust the sponsor to pay them ... is vital that sponsors and CROs establish payment strategies that encourage sites to work ...
(Date:6/27/2017)... (PRWEB) , ... June 27, 2017 , ... ... payment solution for many of the health care industry’s hospitals and provider groups, ... patient financing portal for select customers. Parasail Health is a San Francisco health-finance ...
(Date:6/27/2017)... ... June 27, 2017 , ... Building ... SUNucate efforts, Louisiana became the sixth state to pass legislation which ensures that ... Bel Edwards’ signature, Louisiana joins the states of Alabama, Arizona, Florida, Utah and ...
(Date:6/27/2017)... (PRWEB) , ... June 27, 2017 , ... A January ... been projected to reach a staggering $6.81 billion by the year 2024 according to ... at a faster rate than those made from titanium. Los Angeles area clinic Beverly ...
(Date:6/27/2017)... ... 2017 , ... The Kelahan Agency, a privately owned firm ... southern New Hampshire, is teaming up with the New Horizons for New Hampshire ... the region. , New Horizons for New Hampshire provides a wealth of services ...
Breaking Medicine News(10 mins):
(Date:6/14/2017)... 14, 2017  ivWatch LLC, a medical device company ... (IV) therapy, is pleased to announce it was the ... Hospital Supplies and Equipment at the 2017 Medical Design ... medtech industry. The award was presented by Medical Device ... Center in New York during ...
(Date:6/14/2017)... -- In 2016, Embodied Labs took top prize ... came away with $25,000 in seed-fund investment. Embodied Labs ... "entering the life of another" and by the Journal ... medical professionals in an entirely new dimension." Building upon ... for the Department of Education,s EdSimChallenge, where they received ...
(Date:6/12/2017)... Kineta, Inc., a biotechnology company focused on the ... President of R&D and Head of Virology Kristin Bedard has ... the Northwest and Beyond meeting sponsored by Life Science ... from 8:30-10:30 AM PDT at the Agora Conference Center in ... Bedard will be joined by other leaders in infectious disease ...
Breaking Medicine Technology: